[RDHL] YoY Quarter Result on 30-Jun-2022 [#Q2]

Stock
[RDHL] RedHill Biopharma Ltd.
Announcement Date
07-Nov-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- 16.77%
YoY- 51.02%
Quarter Report
RDHL's Result
RDHL's Financial Summary
View:
Show?
Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 1,796 18,346 21,502 20,899 1,563 2,350 483 24.45%
PBT 761 -11,711 -29,121 -16,047 -10,908 -11,118 -11,023 -
Tax 0 2,552 15 108 1,546 156 2,523 -
NP 761 -14,263 -29,121 -16,047 -10,908 -11,118 -11,023 -
Tax Rate 0.00% - - - - - - -
Total Cost 1,035 32,609 50,623 36,946 12,471 13,468 11,506 -33.05%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin 42.37 -77.74 -135.43 -76.78 -697.89 -473.11 -2,282.19 -
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
EPS 4.83 -10.04 -24.95 -17.95 -15.38 -20.84 -25.69 -
EPS Diluted 4.83 -10.04 -24.95 -17.95 -15.38 -20.84 -25.69 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.